Accredited Live Webinars

Live Webinars

Thursday, October 17, 2019 at 2:00 PM Eastern / 11:00 AM Pacific

While immunotherapy has revolutionized care for metastatic urothelial cancer, it doesn't work for everyone. Patients who progress with or fail immunotherapy will need subsequent therapy, and there is limited data to guide treatment selection. New data from late-stage clinical trials introduce emerging targeted agents with great promise in improving outcomes for these patients.

Don't miss this interactive webinar where experts in bladder cancer and managed care will discuss:

Current strategies for evidence-based treatment decision-making for heavily pretreated patients

Evaluate challenges and barriers to treatment and management of patients with metastatic urothelial cancer following immune checkpoint inhibitors

Assess clinical evidence for emerging targeted agents as therapeutic options for patients unresponsive to or progressing on immunotherapies

Integrate managed care considerations for novel agents based on efficacy and safety data and the value of biomarkers in therapeutic decision-making

This activity is provided by PRIME Education. There is no fee to participate. This activity is supported by an educational grant from Astellas and Seattle Genetics.

In support of improving patient care, PRIME® is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.This activity was planned by and for the healthcare team, and learners will receive 1.0 Interprofessional Continuing Education (IPCE) credits for learning and change.

Physician Credit Designation Statement

PRIME® designates this Enduring material for a maximum of 1.0AMA PRA Category 1 Credits. Physicians should claim only credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Pharmacist Accreditation Statement

This Application-based activity has been approved for 1.0 contact hour (0.1 CEUs) by PRIME® for pharmacists. The Universal Activity Number for this activity is JA0007144-0000-19-070-L01-P. Pharmacy CE credits can be electronically submitted to the NABP upon successful completion of the activity. Pharmacists with questions can contact NABP customer service (custserv@nabp.net).

Nurse Accreditation Statement

PRIME® designates this activity for 1.0 contact hour.

Instructions to Obtain Credit

Register using the online form

Complete the pre-survey

Attend the live program in its entirety

Complete an online evaluation and post-test

Print your certificate online

Method of Participation

CE credit awards require attendance at the entire program and completion of learner assessment tools, after which the learner can print a certificate of completion.